Möchten Sie immer auf dem neuesten Stand bleiben?

Cenrifki (tolebrutinib) de Sanofi approuvé dans l’UE comme premier médicament ciblant la progression du handicap dans la sclérose en plaques secondairement

Press Release June 23, 2026 Capital Markets Day 2026: Signify introduces strategy to create a more focused, better-performing company 2029 medium-term objectives and updated capital allocation...

Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), June 23, 2026 dsm-firmenich, innovators in...

Akkodis Studie: Vertrauen in KI‑Skalierung sinkt, obwohl Investitionen steigen. Herausforderung: Integration statt Technologie, Fokus verschiebt sich zu In

Akkodis study: confidence in AI scaling declines despite rising investment. Challenge shifts to integration, with focus moving from efficiency to innovatio

The shares in SalMar ASA will be quoted ex-dividend of NOK 10.00 per share as from today, 23 June 2026. This information is subject of the disclosure requirements pursuant to section 5-12 of the...

Aksjene i SalMar ASA noteres eks. utbytte på NOK 10,00 per aksje fra og med i dag, 23. juni 2026. Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 ...

DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- Recently, regulatory oversight of digital assets in Europe has continued to intensify. SKHTU Exchange has formally submitted its license application...

DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- Baru-baru ini, penguatkuasaan kawal selia Eropah terhadap aset digital terus meningkat. Bursa SKHTU telah menyerahkan dokumen permohonan lesen secara...

Bangalore, India, June 22, 2026 (GLOBE NEWSWIRE) -- Hybrid-work and home seating rentals gain traction across India's major IT hubs as freelancers, startup teams, students, and transient residents...